IRCT20220806055625N2
Completed
Phase 3
Comparison of the Effect of vitamin E Supplementation on the Treatment of Neonates with Hyperbilirubinemia: A Double-blind Randomized Clinical Trial
Sanandaj University of Medical Sciences0 sites70 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sanandaj University of Medical Sciences
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Term infants with hyperbilirubinemia admitted to the neonatal department of Besat Sanandaj Hospital in 1401
- •Gestational age from 37 weeks to 42 weeks and 6 days
- •Birth weight from 2500 Grams to 4000 Grams
Exclusion Criteria
- •Evidence of infection
- •Congenital malformation
- •History of phenobarbital use in mother
- •Hypothyroidism
- •Inappropriate intrauterine growth
- •Oral intolerance
- •Mechanical ventilation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The effect of treatment with vitamin E compared with relaxation in the treatment of restless legs syndrome (RLS) in HD patientsrestless legs syndrome.Other specified extrapyramidal and movement disordersIRCT2016082129463N1Shahroud University of Medical Sciences90
Completed
Not Applicable
Effect of vitamin E in the treatment of UTI in childrerinary Tract Infection.Urinary tract infection, site not specifiedIRCT201305199766N2Arak University of Medical Sciences152
Completed
Not Applicable
Evaluation of the effect of vitamin E in chronic periodontitisChronic periodontitis.Chronic periodontitisK05.3IRCT20110109005570N10Esfahan University of Medical Sciences16
Recruiting
Phase 2
The effect of combination therapy of vitamin E and C supplements plus Platelet-Rich Plasma-Fibrin Glue on biochemical factors, oxidative stress markers and wound healing rate in diabetic patientsIRCT20190526043711N1Mashhad University of Medical Sciences24
Completed
Phase 3
Effectiveness of Vitamin E as an add on with standard therapy and its effect on patients with chronic kidney disease on renal dialysisHealth Condition 1: N185- Chronic kidney disease, stage 5CTRI/2021/08/036020SRM Institute of Scince and Technology152